BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)
$9.04 +1.57% (delayed · 2026-09-04)
Research BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT): delayed quotes, charts, headlines, earnings calendar events, and SEC 10-K / 10-Q / 8-K filings on tkrhub.
BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) $9.04 +1.57% — delayed US quotes, charts, news & SEC filings on tkrhub. PHARMACEUTICAL PREPARATIONS. R
What you can review
- Delayed session quotes and daily charts
- Related headlines and press context
- Earnings / catalyst calendar windows
- SEC 10-K, 10-Q, and 8-K filings in-app
tkrhub is a US equity research desk — not a broker. Quotes are typically delayed ~15 minutes.